Blood biomarkers in the NAKO Gesundheitsstudie (German National Cohort) at midterm of the first re-examination: descriptive analysis of blood biomarkers from participants enrolled at the Berlin-North study center

Nutzungsanzeige

KeyNAKO-804

Project leadProf. Dr. Tobias Pischon

Approval date12.12.2022

Published date13.12.2022

Linked projectsNAKO-521

SummaryThe aim of this proposal is to characterize the completeness and plausibility of biomarkers from NAKO participants re-examination enrolled at the Berlin-North study center (Max-Delbrück Center-MDC). Furthermore, we aim to analyze the intra and inter-individual variability of biomarkers over 4-5 years.

Keywords-

InstitutionsMax-Delbrück-Centrum für Molekulare Medizin (MDC), Max-Delbrück-Centrum für Molekulare Medizin, Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC), Max Delbrück Centrum für Molekulare Medizine

Go back